Benzinga

Benzinga

Benzinga

lunes, agosto 24

Indaptus Therapeutics Inc

INDPNASDAQ
Trade with Public
Trade with Public
$1.18
-0.11-8.53%
Últ. Act.: Aug 24, 12:03 PM
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Indaptus Therapeutics Financials

Indaptus Therapeutics (INDP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Indaptus Therapeutics Q2 EPS $(0.02) Beats $(1.57) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(1.57) by 98.73 percent. This is a 99.78 percent increase over losses of $(9.09) per share
Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
Indaptus Therapeutics Q1 EPS $(0.23) Beats $(1.87) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(1.87) by 87.7 percent. This is a 97.43 percent increase over losses of $(8.96) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q3 EPS $(2.98) Beats $(4.17) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(2.98) per share which beat the analyst consensus estimate of $(4.17) by 28.54 percent. This is a 67.04 percent increase over losses of $(9.04) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q2 EPS $(9.09) Beats $(9.24) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(9.09) per share which beat the analyst consensus estimate of $(9.24) by 1.62 percent. This is a 30.93 percent increase over losses of $(13.16) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q1 EPS $(0.32) Misses $(0.18) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 28.89 percent increase over losses of $(0.45) per
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved